An early-stage venture capital firm based in Toronto, Canada is making medtech investments out of its third fund. The firm generally looks to make investments in companies ranging from $1 – $5 million initially and up to $10 million over the life of the investment. The firm is focused on Canadian companies, but will work with companies in the Northeastern and Midwestern U.S. as well. The firm aims to make approximately 2-3 new investments per year.
Within the life science space, the firm is looking for medical device and diagnostics companies that have a clear path to FDA approval, and will look at any devices/diagnostics, pre-FDA approval including 510(k) and PMA pathways. In addition to medtech, the firm is also interested in health IT with the focus being on B2B software-centric companies. The firm is looking for companies that have managed to demonstrate market interest in their product prior to investment.
The firm looks to be a very active investor in chosen companies and always pursues a board seat. The firm looks for strong experienced management teams and looks to bring their own entrepreneurial experience to aid in the growth and expansion of companies.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com